Memphis Pharmaceuticals (MPCI.CA) Reports 3 Months Results
Company Name : Memphis Pharmaceuticals
ISIN Code : EGS38351C010
Currency : EGP
F/S Period : From 01/07/2021 To 30/09/2021
Net Loss : 4,416,251
F/S Period: From 01/07/2020 To 30/09/2020
Net Comparative Loss : 8,029,663
Audit Status : Reviewed
Source : Memphis Pharmaceuticals
ISIN Code : EGS38351C010
Currency : EGP
F/S Period : From 01/07/2021 To 30/09/2021
Net Loss : 4,416,251
F/S Period: From 01/07/2020 To 30/09/2020
Net Comparative Loss : 8,029,663
Audit Status : Reviewed
Source : Memphis Pharmaceuticals
Comments